A novel experimental drug for early Parkinson's disease (PD) yielded similar results as commercially available pramipexole extended-release (ER) but with significantly less daytime sleepiness, a new ...

Pramipexole dihydrochloride extended-release 0.375mg, 0.75mg, 1.5mg, 2.25mg, 3mg, 3.75mg, 4.5mg; tabs. Swallow whole. May take with food. Initially 0.375mg once daily ...

Arthritis & Rheumatism. 2005;52(8):2495-2505. The mechanism of fibromyalgia, a chronic illness characterized by muscle pain, fatigue, and sleep disturbances, is unknown and medications used to ...

Drugs commonly prescribed to treat Parkinson's disease have been linked to impulse control disorders such as pathological gambling, compulsive buying, hypersexuality and binge eating in some patients, ...

The mechanism of fibromyalgia, a chronic illness characterized by muscle pain, fatigue, and sleep disturbances, is unknown and medications used to treat it (such as antidepressants, antiepileptics, ...

Medications used to treat impulsivity linked to Parkinson’s drugs Mirapex (pramipexole) and Requip (ropinirole) may be ineffective, a preliminary study has found. In fact, selective serotonin reuptake ...

We treat restless legs syndrome with Parkinson’s drugs, such as pramipexole (Mirapex). Will these drugs remain effective for treating Parkinson’s should the patients develop that condition later in ...

CHICAGO – The drugs levodopa and pramipexole both appear to be reasonable options as initial therapy for Parkinson disease, but they are associated with different efficacy and adverse effects, ...

NEW YORK (Reuters Health) - As a treatment strategy for early Parkinson's disease, initial therapy with levodopa versus pramipexole appears to be comparable in delaying the progression of this ...